D'Orazio & Associates’s Zimmer Biomet ZBH Stock Holding History

D'Orazio & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-141	Closed	-$20K	–	731
2021 Q3	$20K	Hold	141	–	–	﹤0.01%	402
2021 Q2	$22K	Hold	141	–	–	0.01%	249
2021 Q1	$22K	Sell	141 -2	-1%	-$310	0.01%	232
2020 Q4	$21K	Buy	143 +2	+1%	+$282	0.01%	219
2020 Q3	$19K	Hold	141	–	–	0.01%	198
2020 Q2	$16K	Hold	141	–	–	0.01%	212
2020 Q1	$14K	Sell	141 -18	-11%	-$2.36K	0.01%	209
2019 Q4	$23K	Hold	159	–	–	0.01%	201
2019 Q3	$21K	Buy	159 +18	+13%	+$2.33K	0.01%	206
2019 Q2	$16K	Hold	141	–	–	﹤0.01%	217
2019 Q1	$17K	Hold	141	–	–	0.01%	205
2018 Q4	$14K	Hold	141	–	–	﹤0.01%	209
2018 Q3	$18K	Buy	141 +25	+22%	+$2.97K	0.01%	189
2018 Q2	$13K	Hold	116	–	–	0.01%	195
2018 Q1	$12K	Hold	116	–	–	﹤0.01%	197
2017 Q4	$14K	Hold	116	–	–	﹤0.01%	200
2017 Q3	$13K	Hold	116	–	–	﹤0.01%	189
2017 Q2	$15K	Hold	116	–	–	0.01%	209
2017 Q1	$14K	Hold	116	–	–	0.01%	200
2016 Q4	$12K	Hold	116	–	–	﹤0.01%	192
2016 Q3	$14K	Hold	116	–	–	0.01%	183
2016 Q2	$14K	Hold	116	–	–	0.01%	189
2016 Q1	$12K	Buy	+116	New	+$11.2K	0.01%	207

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D'Orazio & Associates's ZBH Position: Q4 2021 in Review

D'Orazio & Associates sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 141 shares — an estimated $20K sold.

D'Orazio & Associates first reported a position in ZBH in Q1 2016 and held it in 23 quarters. The position peaked at $23K in Q4 2019. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

D'Orazio & Associates reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 141 Zimmer Biomet shares in Q4 2021, an estimated $20K.
D'Orazio & Associates first reported a position in Zimmer Biomet in Q1 2016 and held it in 23 quarters.
D'Orazio & Associates's Zimmer Biomet position peaked at $23K in Q4 2019.
998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.